Bicara Therapeutics Inc (NAS:BCAX)
$ 24.28 +0.73 (+3.1%) Market Cap: 1.61 Bil Enterprise Value: 1.11 Bil PE Ratio: 0 PB Ratio: 3.41 GF Score: 14/100

Q2 2026 Bicara Therapeutics Inc Earnings Call Transcript

Aug 11, 2026 / 12:30PM GMT
Release Date Price: $23.76 (-14.32%)
Operator

Good day and thank you for standing by.

Welcome to the Bakara.

Therapeutics Second Quarter 2026 Earnings Conference Call.

(Operator Instructions)

At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you need to press *11 on your telephone. You will then hear an automated message advising your hand is raised.

To infer your question, please press *11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today. Rachel Frank, please go ahead.

Rachel Frank
Bicara Therapeutics Inc - Vice President of Investor Relations

Thank you, and good morning, everyone. It's a pleasure to welcome you to Bycara Therapeutics' second quarter 2026 earnings call. Earlier this morning, we issued a press release highlighting results from the quarter and provided a business update, including strategic leadership transitions marking the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot